Insights on Various Antiviral Drugs for Treating Patients with COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the cause of the
first pandemic of the twenty-first century, which began in Hubei Province, China, in late …
first pandemic of the twenty-first century, which began in Hubei Province, China, in late …
[PDF][PDF] Combatting SARS-CoV-2: Potential Therapeutic Candidates Against COVID-19
PK Gupta, S Kulkarn - EMJ All. & Immun., 2021 - emjreviews.com
Abstract Background: COVID-19, a global pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and has …
syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and has …
[PDF][PDF] Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.
OBJECTIVE: As a beta-coronavirus, Coronavirus disease-2019 (COVID-19) has caused one
of the most significant historical pandemics, as well as various health and medical …
of the most significant historical pandemics, as well as various health and medical …
Current perspective of antiviral strategies against COVID-19
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …
Pharmacological strategies for COVID-19-A review of the most promising repurposed antiviral drugs
D Chopra, JK Boparai, B Bhandari… - … Current Drug Targets …, 2021 - ingentaconnect.com
A novel coronavirus, SARS-CoV-2 (2019-nCoV), emerged in December 2019 as an
immediate global challenge. Comprehensive efforts at the present time are focused …
immediate global challenge. Comprehensive efforts at the present time are focused …
Pipeline pharmacological therapies in clinical trial for COVID-19 pandemic: a recent update
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the …
responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the …
A Therapeutic Journey of Potential Drugs Against COVID-19
Coronavirus disease (CoVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) scrambles the world by infecting millions of peoples all over the globe. It …
2 (SARS-CoV-2) scrambles the world by infecting millions of peoples all over the globe. It …
Therapeutic Development and Drugs for the Treatment of COVID-19
VK Maurya, S Kumar, MLB Bhatt, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
Abstract SARS-CoV-2/novel coronavirus (2019-nCoV) is a new strain that has recently been
confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries …
confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries …
[HTML][HTML] Potential Drugs for Treating COVID-19 Infection
: The novel Coronavirus Disease 2019 (COVID-19) appeared as an emerging respiratory
disease in December 2019 in Wuhan, Hubei province, China, and then spread rapidly …
disease in December 2019 in Wuhan, Hubei province, China, and then spread rapidly …
[PDF][PDF] COVID-19 infection: The prospects of pharmacotherapy
SM Patil, VC Kumari, PS Shirahatti… - … Journal of Health & …, 2020 - researchgate.net
The disastrous outbreak of coronavirus disease 2019 (COVID‑19) has triggered the
investigation of several therapeutic options following the redundancy of specific drugs …
investigation of several therapeutic options following the redundancy of specific drugs …